Relationship of Gait and Cognition in the Elderly

  • Raminder Parihar
  • Jeannette R. Mahoney
  • Joe Verghese
Neurology of Aging (KS Marder, Section Editor)

DOI: 10.1007/s13670-013-0052-7

Cite this article as:
Parihar, R., Mahoney, J.R. & Verghese, J. Curr Transl Geriatr and Exp Gerontol Rep (2013) 2: 167. doi:10.1007/s13670-013-0052-7
  • 818 Downloads

Abstract

Gait and cognitive impairments in older adults mostly reflect the co-occurrence of two geriatric syndromes linked by common underlying brain substrates and pathologies. Gait control is predominately mediated by frontal subcortical circuits, which overlap with circuits controlling executive control and attention functions. These circuits are vulnerable to multiple age-related pathologies such as ischemia, inflammation, and neurodegeneration, which could ultimately cause cognitive, gait, or combined cognitive and gait impairments. The following review aims to describe various gait and cognitive classifications, gait based phenotypes, common underlying pathological processes, and provide a link between motor and cognitive impairments in an effort to predict the risk of dementia and remediate impairments by applying appropriate interventions.

Keywords

GaitCognitionGait phenotypesInflammationNeurodegenerationVascularQuantitative gait measurementsDual-taskDementia riskRemediation

Introduction

According to the U.S. Census projections, the current population of adults age 65 and older will more than double between now and 2060, from 43.1 to 92.0 million [1]. This growing aging segment of the population has brought added urgency to understanding the normal aging process, as well as age related diseases. Typically, the ‘normal aging’ process entails a myriad of alterations in sensory, motor, and cognitive functions that have been linked to poor quality of life [24], functional decline [5], increased risks of falls [69], and impaired mobility [5]. Additionally, disease-related motor impairments, including gait disorders and slowing of movements, are increasingly common with advancing age. A population-based study in the U.S. showed a 35 % prevalence of clinically diagnosed gait disorders among community-dwelling persons over age 70 [10]. The prevalence of cognitive impairments of varying severity also increases with age, with one study reporting that 17 % of adults age 65 years and older in their population-based cohort had cognitive impairments without meeting criteria for dementia and 8 % had frank dementia [11]. Increasingly, the co-existence of both gait and cognitive impairments in aging has also been recognized. For instance, Camicoli and colleagues reported that gait and postural impairments were seen in 25 to 30 % of cognitively normal participants and in 46 to 53 % of cognitively impaired participants in the Canadian Study of Health and Aging [12].

While the co-occurrence of gait and cognitive impairments in older adults may reflect a simple co-existence of common age-related syndromes [12], others have proposed that the co-occurrence of these two geriatric syndromes may be related to a common underlying pathology [13, 14]. Intact gait control requires the efficient integration of many neural systems, including motor, sensory, and cognitive processes, and cognitive sub-systems such as memory, attention, and executive function [13, 15]. Gait control is predominately mediated by frontal subcortical circuits; circuitry which is also known to mediate executive control and attention functions [16, 17]. Furthermore, the ‘normal aging’ process renders this circuitry vulnerable to multiple pathologies, such as ischemia, inflammation, and neurodegeneration, which in turn could potentially trigger cognitive, motor, or combined cognitive and motor impairments in older patients [1820].

In the following sections, we review gait and cognitive classifications, common pathological processes for cognitive and motor syndromes, clinical utility of diagnosing combined gait and cognitive impairments, and discuss emerging intervention strategies that build on the interplay between gait and cognitive functions.

Phenotyping Gait and Cognition

Clinical Gait

Gait impairments can be classified as either neurological or non-neurological subtypes following clinical examination of walking patterns. Neurological gait abnormalities result from focal or diffuse lesions affecting the neural pathways that link cortical motor centers to the peripheral neuromuscular systems [21]. Neurological gait abnormalities are further classified into: unsteady, ataxic, neuropathic, frontal, Parkinsonian, hemiparetic and spastic subtypes [21, 22]. Non-neurological gait abnormalities result from physical limitations to walking, such as arthritis or foot deformities and do not involve the neuroaxis. Combinations of neurological or non-neurological subtypes also exist in older adults.

An alternate clinical gait classification divides gait abnormalities into low, middle and high level disorders [23, 24]. In low level gait disorders, only one major afferent sensory system (visual, proprioceptive, or vestibular) is affected. Middle level disorders result from spasticity (due to myelopathy from cervical spondylosis and stroke), Parkinsonism, or cerebellar ataxia. High level gait disorders include cautious gait, frontal gait disorders, and psychogenic gait disorders, and are thought to result from disruptions in cortico-cortical and cortico-subcortical connections.

The reliability and validity of most descriptive gait classification systems have not been verified and many gait subtypes overlap. For instance, the terms marche a petit pas, cautious gait, and apractic gait are used to describe gait abnormalities that share clinical features such as slowness, short steps, or wide base with frontal gaits. This lack of consistency may in part explain why there is a paucity of studies that have employed clinical gait subtypes, an essential part of the neurological evaluation, to predict geriatric outcomes.

Accurate identification of neurological gait sub-types enables anatomical localization of lesions, guides investigations, and provides hints to the underlying pathology. Identifying gait subtypes is also helpful in risk prognostication for motor and cognitive outcomes in clinical practice. For instance, neuropathic gaits that present with foot drops were reported to be associated with increased risk for falls [25], whereas frontal gait disorders that present with short shuffling steps with difficulty lifting the feet off the ground were reported to be associated with increased risk of developing dementia, especially vascular dementia [21].

Cognitive Syndromes

Cognitive disorders, unlike gait disorders, are categorized on a spectrum of cognitive decline, beginning with cognitive normalcy, transitioning to intermediate states such as the mild cognitive impairment (MCI), and often reaching an endpoint of dementia. MCI is defined as an impairment in one or more domains of cognitive function, without interference in daily activities in non-demented individuals [26]. It is further sub-classified into three categories: one that predominately involves memory impairments (amnestic MCI); a second that involves impairments in cognitive domains other than memory (non-amnestic MCI), such as executive function, language, or visuospatial impairments; and a third that involves multiple impairments across both memory and other cognitive domains (combined MCI) [27]. Patients who meet MCI criteria in clinical practice are at higher risk of transitioning to dementia [28].

Presence of neurological gait subtypes as well as quantitative gait impairments have been linked to MCI [21, 29, 30]. Recent studies suggest that gait slowing may precede declines in cognitive tests in older adults [31, 32•]. Hence, gait may complement cognitive assessments in MCI. The role of gait assessment in predicting transitions to dementia in MCI patients requires further investigation.

Quantitative Gait

When gait impairments are subtle, they may not be detected by the untrained eye. Quantitative measures provide an objective means of assessing gait that minimizes examiner bias. In our studies, a computerized walkway with embedded pressure sensors (GAITRite, CIR systems) is used to measure gait [29, 33, 34]. Participants are asked to walk on the mat at their ‘normal pace’ in a quiet well-lit hallway wearing comfortable footwear and without any attached monitoring devices. Based on footfalls recorded on the walkway, the software automatically computes numerous gait variables. We employ eight parameters to describe gait performance [3335]: velocity (cm/sec); cadence (steps/minute); stride length (cm); swing time (sec); stance time (sec); and double support phase (%); as well as standard deviation (SD) of stride length and SD of swing time, both of which serve as proxies for gait variability [29]. Gait variability has been linked to increased risk of falls and dementia in older adults [34, 35].

These eight gait variables have been subjected to factor analysis to derive gait domains of pace, rhythm, and variability [34, 35]. This statistical approach accounts for co-linearity between individual gait variables, as well as affords an opportunity to assess specific gait domains. In our and other studies [34, 35], the pace factor was accounted for by velocity and stride length, while the rhythm factor was accounted for by cadence and timing, and the variability factor by gait variability in stride length and swing time. While the pace domain predicted decline in executive function, rhythm predicted decline in memory, and gait variability predicted risk of dementia [34]. Thus, particular facets of gait were linked to specific cognitive domains, raising the possibility of a shared biology between circuitry.

Early motor dysfunction, assessed by presence of gait slowing, co-exists with or even precedes the onset of cognitive decline in older adults [36]. It is assumed that stride length and velocity, factors that load on pace, are controlled by phasic output from the basal ganglia to the supplementary motor area, whereas spinal and brainstem pathways determine cadence (rhythm) [37]. Parkinsonian gait has been correlated with presence and severity of substantia nigra neurofibrillary tangles, even in brain autopsy studies of individuals without clinical Alzheimer’s disease or with minimal Alzheimer pathology [38]. Therefore, it is possible that Alzheimer pathology may involve gait regions in the brain very early on in its course, and quantitative gait assessments could provide early diagnostic clues.

Linking Gait and Cognition

Attention and Gait

Converging evidence from clinical, neuroscience, and neuroimaging studies indicate a major role for executive attention processes and frontal-subcortical circuits in mobility in older adults [13, 14, 18, 39, 40]. Increased levels of attention are associated with better gait performance [15, 4143]. This association is best demonstrated using dual-task methodology, which simultaneously assesses cognitive and motor task performance by requiring individuals to walk while performing a cognitively demanding task. For instance, the ‘Walking While Talking’ test is a cognitive-motor divided attention task that requires individuals to walk while reciting alternate letters of the alphabet. The goal of this test is to unmask latent mobility abnormalities by increasing the complexity of the walking condition [4346]. In this paradigm, gait parameters such as velocity and stride length in the dual-task condition (walking while talking) can be directly compared to gait parameters in the single-task condition (walking without talking) [47]. Changes in gait performance during the dual-task (also called ‘dual task cost’) support the functional role of attention during walking. Our work indicates that cognitive domains such as executive attention and memory are associated with velocity during normal pace walking as and walking while talking; supporting the notion that walking is a complex task requiring the involvement of higher-order cortical control processes [13].

The clinical utility of dual-task conditions has been reported; gait speed during walking while talking is a strong predictor of risk of falls [45]. The walking while talking test might also serve as a mobility stress test by increasing the cognitive demands of walking. For instance, the walking while talking test predicted future risk of developing frailty, disability and death in high functioning non-disabled older adults with normal walking speeds [48].

Motor Cognitive Risk Syndrome

Despite growing evidence of the link between cognition and motor performance in aging, there have been limited attempts to capitalize on these findings in dementia risk prognostications. The recently described Motoric Cognitive Risk (MCR) syndrome attempts to identify individuals who are at high-risk for developing dementia [49•]. A patient meets criteria for the MCR syndrome if he/she demonstrates 1) cognitive complaints; 2) slow gait (velocity one SD or more below age and sex appropriate mean values); 3) preserved activities of daily living (ADL); and 4) absence of dementia. Thus, the MCR criteria are similar to those employed to define MCI, with the exception of the objective cognitive criteria in MCI being substituted by the slow gait requirement in MCR syndrome. MCR has strong predictive validity for dementia: older participants meeting criteria for MCR were over three times likely to develop dementia and more than twelve times likely to develop vascular dementia. Interestingly, MCR syndrome was a better predictor of dementia than cognitive complaints or slow gait alone. While there is overlap between MCR and MCI cases, MCR syndrome still predicted risk of dementia after accounting for MCI subtypes.

Gait and Cognitive Disorders Share Common Pathology

Herein, we describe a few selected pathological processes that are common in aging and are associated with decline in cognitive and motor functions. A better understanding of the common pathological processes that contribute to decline in gait and cognitive functions can be used as a springboard to develop new interventions to prevent or diminish gait and cognitive impairments in the elderly.

Vascular

Vascular risk factors such as hypertension can lead to cerebral ischemia secondary to impairment in arterial vasoreactivity, obstruction of small subcortical arterioles, or hypoperfusion [18]. Vascular lesions can be either focal, resulting in lacunar infarctions, seen in the thalamus, basal ganglia, internal capsule or brainstem [50], or diffuse, affecting the periventricular white matter [51]. The periventricular white matter consists of the ascending thalamocortical and descending corticospinal tracts, which sub-serve gait and balance functions [16]. The frontal-subcortical connections, which control speed of cognitive processing and executive function, also travel within the periventricular white matter [17]. Due to the close proximity of these two circuits, white matter lesions (WML) may affect motor and cognitive functions simultaneously. In elderly patients, WML are strongly associated with cardiovascular disease such as hypertension, diabetes, or hyperlipidemia [52]. Research has shown that accumulation of vascular structural abnormalities, in both white and gray matter accounts for cognitive decline [5355] and gait impairment [14, 56, 57]. The severity of periventricular WML is associated with a decline in the speed of mental processing [54], as well as lower performance in fluid intelligence measures [53, 55]. Subclinical white matter hyperintensities, brain infarcts and brain atrophy predicted a faster rate of decline in gait speed over time [56]. In addition to velocity, Rosano and colleagues demonstrated that a decline in stride length, and an increase in step length variability, was indicative of the presence of brain infarcts and white matter hyperintensities in an elderly population free from stroke, dementia, or other neurological diseases [14, 57].

Inflammation

While normal aging is associated with a low-grade systemic inflammation, previous studies have linked higher levels of inflammatory markers to impairments in mobility and physical function in older adults [19, 58, 59]. Cross-sectional studies have demonstrated an association between high serum levels of inerleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) with worsening of functional and mobility status [6062]. However, only elevated serum levels of IL-6 but not TNF-α were associated with increased rates of decline in gait speed when examined prospectively [63]; suggesting that not all inflammatory markers are involved in motoric decline. Inflammation is also implicated in the cascade that leads to the development of amyloid neuritic plaques, one of the pathological hallmarks of Alzheimer’s disease (AD) [64]. Epidemiological studies have identified associations between specific inflammatory markers, such as increased IL-6 levels with a decline in the ability to encode new information and recall learned information; aspects of cognition affected early in AD [65].

Thus, declines in gait speed and memory impairment share a common increase in the same inflammatory markers. Reduction or prevention of inflammation could be explored as a possible new avenue to slow of or halt the progression of cognitive and gait decline in aging [66].

Neurodegeneration

Neurodegenerative diseases, like Parkinson’s disease, also demonstrate the intersection between cognition and motor impairment in that specific facets of cognition have been related to different motor phenotypes [20]. Bradykinesia is associated with reduced mental flexibility and decreased working memory abilities [20]. Presence of postural instability and gait disturbances is associated with impaired visuospatial function and memory [20]. Hence, cognitive impairment co-exists with motor decline even in the early stages of neurodegenerative diseases such as Parkinson’s disease. Imaging studies further support this notion. When dopamine activity was measured in patients with impaired executive function, particularly, impaired working memory, there was a decrease in dopamine activation in both the basal ganglia and/or frontal cortex [67, 68]. Such results signify that diseases resulting from diminished dopamine, not only affect motor abilities, due to basal ganglia involvement, but they also affect cognition, due to involvement of the frontal circuits responsible for executive function.

Interventions

Physical Activity and Dementia Risk

Physical activity contributes to healthy aging and reduces morbidity and mortality [69]. Physical activity has been shown to have protective effects against mortality in patients with chronic diseases such as cardiovascular disease [70]. Many studies have examined the effect of physical activity on cognitive performance in older individuals. For instance, Baker and colleagues demonstrated an improvement in executive function tests in individuals with normal cognition who underwent a 6-month aerobic exercise program compared to healthy controls who participated in a stretching regimen [71]. The researchers further demonstrated an improvement in executive function after a 6-month aerobic exercise program in individuals with MCI [72]. A French study enrolled patients with dementia from a nursing home, half of whom took part in three 60-minute exercise sessions a week that strategically focused on improving walking, stamina and equilibrium [73]. The 31 individuals who underwent the physical intervention showed improvement in composite cognitive functions, while the 16 participants in the usual care control group showed a decline in cognitive functions.

Collectively, these studies support the link between gait and cognition in that physical exercise results in improvements in cognition.

Cognitive Remediation and Mobility

The reverse relationship between cognitive interventions and their effect of gait are being explored in recent studies. Cognitive remediation approaches using computerized programs or cognitive training have demonstrated an improvement in attention and executive function as well as memory in cognitively normal older adults. Verghese and colleagues [74•] conducted a pilot study in which 24 frail older adults were randomly assigned to either participate in a computerized cognitive remediation program or were in a usual care group for a 12-week period. The cognitive remediation group showed an improvement in gait velocity during normal walking and during walking while talking conditions compared to their baseline performance. This small study suggests the possibility that cognitive remediation could be a new, non-pharmacological means of modifying gait performance, especially during dual-task conditions.

Participants who received training in dual-tasking have demonstrated improvements in walking abilities [75, 76]. Schwenk and colleagues evaluated the efficacy of a 12-week dual-task training program in seniors with dementia. The participants were randomized to either a dual-task exercise session, involving walking while performing complex motor or cognitive activities, or a low intensity exercise session [75]. After 12 weeks, the group that received dual-task training performed significantly better on gait in a complex dual- task condition compared to the control group. Mirelman and colleagues examined the efficacy of a treadmill training program enhanced with virtual reality in patients with Parkinson’s disease [76]. After six weeks of training, gait velocity, stride time and stride length significantly improved in normal and dual-tasking conditions, and gait variability decreased (improved) under the dual-task condition.

These early studies support the feasibility and validity of cognitive based approaches to improve mobility. The effect of these interventions seems especially beneficial in cognitively demanding dual-task walking conditions. Larger well-designed studies are needed to further validate this new approach.

Conclusions

Review of the literature suggests that the co-existence of gait and cognitive impairments in older adults is related to a common underlying pathology and is not an age-related phenomenon. Gait control is predominately mediated by frontal subcortical circuits, which overlap with circuits controlling executive control and attention functions. Therefore, any pathological process affecting one circuit could affect the other resulting in combined cognitive and motor impairments in older patients. Clinical and quantitative gait assessments, as well as a clinical gait based phenotypes such as the MCR syndrome, could serve as risk prognosticators in clinical and research settings to predict various geriatric syndromes such as falls, frailty, disability, dementia, and death. Emerging evidence from pilot studies also highlights the potential role of cognitive and motor remediation interventions to prevent further decline in either gait or cognitive function. Further studies are needed to understand the common biology and brain substrates underlying cognitive-motor impairments in aging as a prelude to improving current risk assessment procedures and developing novel interventions to maintain functional independence in older individuals.

Compliance with Ethics Guidelines

Conflict of Interest

Raminder Parihar declares that she has no conflict of interest.

Jeannette R. Mahoney declares that she has no conflict of interest.

Joe Verghese is supported by a grant from the National Institutes of Health (NIH).

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Raminder Parihar
    • 1
    • 4
  • Jeannette R. Mahoney
    • 1
    • 5
  • Joe Verghese
    • 1
    • 2
    • 3
  1. 1.Department of NeurologyAlbert Einstein College of MedicineBronxUSA
  2. 2.Department of MedicineAlbert Einstein College of MedicineBronxUSA
  3. 3.Division of Cognitive & Motor Aging, Saul R Korey Department of NeurologyAlbert Einstein College of MedicineBronxUSA
  4. 4.Saul R Korey Department of NeurologyAlbert Einstein College of MedicineBronxUSA
  5. 5.Division of Cognitive & Motor Aging, Saul R Korey Department of NeurologyAlbert Einstein College of MedicineBronxUSA